“Bimekizumab 4-Year Efficacy in High-Impact Areas in Moderate to Severe Plaque Psoriasis: Pooled Results from BE BRIGHT”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 6, Nov. 2024, p. s432, https://doi.org/10.25251/skin.8.supp.432.